Dimensional Fund Advisors LP Grows Stock Holdings in Bruker Co. (NASDAQ:BRKR)

Dimensional Fund Advisors LP raised its stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,687,364 shares of the medical research company's stock after acquiring an additional 313,171 shares during the period. Dimensional Fund Advisors LP owned approximately 1.11% of Bruker worth $98,914,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its holdings in shares of Bruker by 1.0% during the fourth quarter. Geode Capital Management LLC now owns 2,013,741 shares of the medical research company's stock worth $118,081,000 after purchasing an additional 20,273 shares during the period. FIL Ltd lifted its stake in shares of Bruker by 262.3% in the 4th quarter. FIL Ltd now owns 1,961,416 shares of the medical research company's stock worth $114,978,000 after acquiring an additional 1,420,102 shares during the period. Vaughan Nelson Investment Management L.P. boosted its holdings in shares of Bruker by 140.3% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,141,762 shares of the medical research company's stock valued at $66,930,000 after acquiring an additional 666,617 shares in the last quarter. Norges Bank acquired a new position in shares of Bruker during the fourth quarter worth about $63,378,000. Finally, Bank of New York Mellon Corp raised its holdings in Bruker by 7.6% during the fourth quarter. Bank of New York Mellon Corp now owns 988,863 shares of the medical research company's stock worth $57,967,000 after purchasing an additional 69,806 shares in the last quarter. 79.52% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

BRKR has been the topic of several recent analyst reports. Barclays dropped their target price on Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Stifel Nicolaus cut their price objective on Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a research report on Friday, February 14th. Citigroup decreased their target price on shares of Bruker from $75.00 to $50.00 and set a "buy" rating on the stock in a research report on Monday, April 7th. Guggenheim reiterated a "buy" rating on shares of Bruker in a report on Monday, February 24th. Finally, Wells Fargo & Company decreased their price objective on shares of Bruker from $75.00 to $60.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $65.00.

Bruker Stock Performance

Shares of BRKR opened at $39.07 on Monday. Bruker Co. has a 12-month low of $34.10 and a 12-month high of $82.04. The stock has a market cap of $5.92 billion, a P/E ratio of 51.41, a PEG ratio of 2.16 and a beta of 1.18. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. The company has a 50-day moving average of $43.22 and a two-hundred day moving average of $52.62.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, research analysts predict that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 17th were given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date was Monday, March 17th. Bruker's dividend payout ratio is presently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.